Tyrosine kinase-IN-8

CAT:
804-HY-162489
Size:
Inquire
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Tyrosine kinase-IN-8 - image 1

Tyrosine kinase-IN-8

  • UNSPSC Description:

    Tyrosine kinase-IN-8 (compound 4e) is a BCR‐ABL1 tyrosine kinase inhibitor (TKI). Tyrosine kinase-IN-8 shows anti-proliferative activity against K562 cells, a chronic myeloid leukemia (CML) cell line (CC50=0.8 µM). Tyrosine kinase-IN-8 can be used in the study of chronic leukemia[1].
  • Target Antigen:

    Bcr-Abl
  • Type:

    Reference compound
  • Related Pathways:

    Protein Tyrosine Kinase/RTK
  • Applications:

    Cancer-Kinase/protease
  • Field of Research:

    Others
  • Assay Protocol:

    https://www.medchemexpress.com/tyrosine-kinase-in-8.html
  • Solubility:

    10 mM in DMSO
  • Smiles:

    CC(C=CC(N1C(C2=CC=C(F)C=C2)=NOC13C(C=C(F)C=C4)=C4NC3=O)=C5)=C5NC6=NC(C7=CC=CN=C7)=CC=N6
  • Molecular Weight:

    561.54
  • References & Citations:

    [1]de Azevedo L D, et al. Spirooxadiazoline‐oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells[J]. Archiv der Pharmazie, 2024: e2400029.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported